Cargando…
Modeling to Optimize Terminal Stem Cell Differentiation
Embryonic stem cell (ESC), iPCs, and adult stem cells (ASCs) all are among the most promising potential treatments for heart failure, spinal cord injury, neurodegenerative diseases, and diabetes. However, considerable uncertainty in the production of ESC-derived terminally differentiated cell types...
Autor principal: | Gallicano, G. Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820305/ https://www.ncbi.nlm.nih.gov/pubmed/24278782 http://dx.doi.org/10.1155/2013/574354 |
Ejemplares similares
-
Germ-line stem cells in myocardial regeneration: Secretion of cardiogenic paracrine effectors may be the future
por: Gallicano, G. Ian
Publicado: (2018) -
Re-Defining Stem Cell-Cardiomyocyte Interactions: Focusing on the Paracrine Effector Approach
por: Mahapatra, Samiksha, et al.
Publicado: (2018) -
PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production
por: Mobley, Stephen, et al.
Publicado: (2010) -
Cardiac inducing colonies halt fibroblast activation and induce cardiac/endothelial cells to move and expand via paracrine signaling
por: Mahapatra, Samiksha, et al.
Publicado: (2022) -
Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System
por: Han, Ruijun, et al.
Publicado: (2012)